Pegasus Moves to Brighton
April 29, 2014 |
Top UK Healthcare Communications Consultancy Moves to Brighton
‘Oh we do like to be beside the seaside!’ Pegasus returns to its roots in Brighton
As it approaches 20 successful years of business, Worthing based firm Pegasus, the fourth biggest independent health communications consultancy in the UK, is moving the company to its seaside neighbour, Brighton.
Keen to stay by the sea, the company is making the short journey along the coast to neighbouring Brighton, positioning itself within the heart of the North Laines on Church Road’s ‘Sovereign House’. The move was prompted by a number of factors; the growing number of staff living in Brighton & Hove and the surrounding area; the strength of its digital and creative offering, and the recruitment pull of being by the sea and at the end of the London commuting line.
The company’s time in Worthing has seen many successes including significant growth, scores of awards and the launch of new integrated services. In the last six years alone, staff numbers have grown from 20 to a team of 70. Tripling its income, the consultancy has become a top four UK healthcare comms consultancy and was recently ranked 22nd on The Sunday Times ‘100 Best Places to Work’ (2014).
Lisa Bradley, Founder & Managing Director of Pegasus says; “Whilst Worthing has been a good home for us and helped us get to where we are today, Brighton is actually where the company began all those years ago…in Hove actually. In many ways it feels like we’re coming home! Brighton offers new opportunities that we are keen to uncover, and being the digital hub of the UK will allow us to strengthen our digital division further. We look forward to supporting the business community and hope to integrate ourselves as well as we have in Worthing.”
Pegasus has evolved from a traditional PR agency to become an integrated comms consultancy that offers a multiservice approach to its clients, including; social, digital and creative services.
With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as; GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil and Danone to name a few. As of the 28th of April, Pegasus’s new address will be: Sovereign House, North Laines, Church Street, BN1 1UJ
This content was provided by Inizio
Company Details
Latest Content from Inizio
Webinar: The Brazil Conundrum
Conducting research in one of the world’s largest pharma markets
Webinar: Demand calibration: What’s inside the black box?
The process of demand calibration of preference share (down-weighting) is often a proprietary “black box” technique, which can mean that the client is unsure how the calibrated figure has been…
Free Thinking: Behavioural economics
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Article: The Colombia Conundrum
Published in eye for pharma 30 January by Marc Yates
Ageing in China: The Implications for Healthcare
Published in eye for pharma 12 December by Marc Yates
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?
Published in Eye for Pharma 10 November by Marc Yates
Pegasus picks up “Specialist Consultancy of the Year” at the PRCA Awards 2014
Pegasus, the UK’s leading independent health communications consultancy, picked up the “Specialist Consultancy of the Year” award at the PRCA Awards 2014.
Pegasus supports unique theatrical performance as part of the 9th UK Dementia Congress
Brighton-based Pegasus, the UK’s leading independent health communications consultancy, is pleased to be supporting Naomi’s Flight – a bold and unique theatrical performance tour that highlights the impact of dementia…
It’s a hat trick for Pegasus!
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
Exploring MINT: Part 4 – Turkey
In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in…